Evidence map›Paper›PMID 39333699›Full record

ArticleScientific reports2024

Enhancing brain tumor classification through ensemble attention mechanism.

Fatih Celik, Kemal Celik, Ayse Celik

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Fatih CelikDepartment of Geomatic Engineering, Yıldız Technical University, Esenler, Istanbul, Turkey. F.alpcelik@gmail.com.
Kemal CelikDepartment of Geomatics Engineering, Gumushane University, Gumushane, Turkey.
Ayse CelikGumushane University, Kelkit Aydın Dogan Meslek Yuksekokulu, Gumushane, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain tumors pose a serious threat to public health, impacting thousands of individuals directly or indirectly worldwide. Timely and accurate detection of these tumors is crucial for effective treatment and enhancing the quality of patients' lives. The widely used brain imaging technique is magnetic resonance imaging, the precise identification of brain tumors in MRI images is challenging due to the diverse anatomical structures. This paper introduces an innovative approach known as the ensemble attention mechanism to address this challenge. Initially, the approach uses two networks to extract intermediate- and final-level feature maps from MobileNetV3 and EfficientNetB7. This assists in gathering the relevant feature maps from the different models at different levels. Then, the technique incorporates a co-attention mechanism into the intermediate and final feature map levels on both networks and ensembles them. This directs attention to certain regions to extract global-level features at different levels. Ensemble of attentive feature maps enabling the precise detection of various feature patterns within brain tumor images at both model, local, and global levels. This leads to an improvement in the classification process. The proposed system was evaluated on the Figshare dataset and achieved an accuracy of 98.94%, and 98.48% for the BraTS 2019 dataset which is superior to other methods. Thus, it is robust and suitable for brain tumor detection in healthcare systems.

Indexed as

Brain NeoplasmsMagnetic Resonance ImagingAlgorithmsHumansImage Interpretation, Computer-AssistedImage Processing, Computer-AssistedAttentionBrain tumorClassificationCNNDeep learning

Identifiers

PMID39333699
PMCPMC11436883

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.